Estimating leukemia-free survival after allografting for chronic myeloid leukemia: a new method that takes into account patients who relapse and are restored to complete remission.

@article{Craddock2000EstimatingLS,
  title={Estimating leukemia-free survival after allografting for chronic myeloid leukemia: a new method that takes into account patients who relapse and are restored to complete remission.},
  author={Charles Craddock and Richard M. Szydlo and John P. Klein and Francesco Dazzi and Eduardo Olavarr{\'i}a and Frits van Rhee and Christopher F E Pocock and Kate Cwynarski and Jane F. Apperley and J M Goldman},
  journal={Blood},
  year={2000},
  volume={96 1},
  pages={86-90}
}
A significant number of patients who relapse after allogeneic stem cell transplantation (SCT) for chronic myeloid leukemia (CML) will achieve sustained remissions after treatment with interferon-alpha, second transplants, or donor lymphocyte infusions (DLI) from the original stem cell donor. Because leukemia-free survival (LFS) is at present defined as survival without evidence of relapse at any time posttransplant, patients who relapse but are then restored to complete remission are treated as… CONTINUE READING
21 Citations
34 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 21 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 34 references

Leukemia free survival after allogeneic transplantation for chronic myeloid leukemia: effect of reclassifying responders to donor lymphocyte infusion as currently free of leukemia [abstract

  • C Craddock, R Szydlo, E Olavarria
  • Blood
  • 1997

Similar Papers

Loading similar papers…